{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:32:34Z","timestamp":1773297154419,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.ejogrb.2012.05.037","type":"journal-article","created":{"date-parts":[[2012,6,23]],"date-time":"2012-06-23T04:32:14Z","timestamp":1340425934000},"page":"161-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome"],"prefix":"10.1016","volume":"164","author":[{"given":"Antoaneta Trifonova","family":"Gateva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdravko Asenov","family":"Kamenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2012.05.037_bib0005","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0010","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0020","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0025","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/humrep\/deg218","article-title":"Cardiovascular risk factors in young Czech females with polycystic ovary syndrome","volume":"18","author":"Vrbikova","year":"2003","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0035","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0002-9378(11)90605-X","article-title":"Lipid and apolipoprotein abnormalities in hirsute women: the association with insulin resistance","volume":"166","author":"Wild","year":"1992","journal-title":"American Journal of Obstetrics and Gynecology"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0040","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/S0002-9343(99)80056-4","article-title":"Obesity, lipids, cardiovascular risk, and androgen excess","volume":"98","author":"Wild","year":"1995","journal-title":"American Journal of Medicine"},{"issue":"10","key":"10.1016\/j.ejogrb.2012.05.037_bib0045","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0050","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(00)02764-1","article-title":"Internal carotid-artery response to 5% carbon dioxide in women with polycystic ovaries","volume":"356","author":"Lakhani","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0055","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1210\/jcem.87.2.8199","article-title":"Altered vascular function in young women with polycystic ovary syndrome","volume":"87","author":"Kelly","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0060","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0065","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1016\/j.ejogrb.2012.05.037_bib0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20\u201324 years, continuing through 32\u201341 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0075","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0080","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/0029-7844(95)00250-U","article-title":"Body fat distribution in women with polycystic ovary syndrome","volume":"86","author":"Douchi","year":"1995","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1016\/j.ejogrb.2012.05.037_bib0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(99)00184-3","article-title":"Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders","volume":"72","author":"Acien","year":"1999","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0090","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/j.1471-0528.2006.00973.x","article-title":"The central issue? Visceral fat mass is a good marker of insulin resistance and metabolic disturbance in women with polycystic ovary syndrome","volume":"113","author":"Lord","year":"2006","journal-title":"BJOG: An International Journal of Obstetrics and Gynaecology"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0095","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1210\/jc.2005-1002","article-title":"Central fat excess in polycystic ovary syndrome: relation with low-grade inflammation and insulin resistance","volume":"90","author":"Puder","year":"2005","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0100","first-page":"1421","article-title":"Cellular insulin resistance in adipocytes from obese polycystic ovary syndrome subjects involves adenosine modulation of insulin sensitivity","volume":"82","author":"Ciaraldi","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0105","first-page":"1147","article-title":"Impaired adipocyte lipolysis in nonobese women with the polycystic ovary syndrome: a possible link to insulin resistance?","volume":"82","author":"Ek","year":"1997","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/humrep\/dem356","article-title":"Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome","volume":"23","author":"Cascella","year":"2008","journal-title":"Human Reproduction"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0115","first-page":"121","article-title":"The associations between obesity, adipose tissue distribution and disease","volume":"723","author":"Bjorntorp","year":"1988","journal-title":"Acta Medica Scandinavica"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0120","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1017\/S0954422410000144","article-title":"A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value","volume":"23","author":"Browning","year":"2010","journal-title":"Nutrition Research Reviews"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0125","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jclinepi.2007.08.012","article-title":"Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis","volume":"61","author":"Lee","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1291","key":"10.1016\/j.ejogrb.2012.05.037_bib0130","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1590\/S1516-31802011000100006","article-title":"Correlation of anthropometric indicators for identifying insulin sensitivity and resistance","volume":"6","author":"Matos","year":"2011","journal-title":"Sao Paulo Medical Journal"},{"issue":"1","key":"10.1016\/j.ejogrb.2012.05.037_bib0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovarian syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-sponsored Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0140","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee","volume":"854","author":"World Health Organisation","year":"1995","journal-title":"WHO Organisation Technical Report Series"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0145","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh report of the Joint Committee on prevention, detection, evaluation and treatment of high blood pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0150","unstructured":"Tolonen H, Kuulasimaa K, Laatikanien T, Wolf H. European Health Risk Monitoring (EHRM). Recommendation for indicators, international collaboration, protocol and manual of operations for chronic disease risk factor surveys. 2002 URL: http:\/\/www.ktl.fi\/publications\/ehrm\/product2\/title.htm."},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0155","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0165","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome. A Joint Interim Statement of the IDF Task Force on Epidemiology and Prevention, NHLBI, AHA, WHF, International Atherosclerosis Society and International Association for Study of Obesity","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0170","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0175","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0180","doi-asserted-by":"crossref","first-page":"931402","DOI":"10.4061\/2011\/931402","article-title":"Waist Circumference. Body mass index, and other measures of adiposity in predicting cardiovascular disease risk factors among Peruvian adults","volume":"2011","author":"Knowles","year":"2011","journal-title":"International Journal of Hypertension"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0185","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2007.08.024","article-title":"ESC Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention inclinical practice: executive summary","volume":"194","author":"Graham","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejogrb.2012.05.037_bib0195","series-title":"Obesity: Preventing and Managing the Global Epidemic: Report on a WHO Consultation (WHO Technical Report Series 894)","author":"World Health Organization","year":"2000"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151200262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121151200262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:27:17Z","timestamp":1759555637000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121151200262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S030121151200262X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.05.037","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2012.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}